Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Induction versus escalation therapy.

V Martinelli1, G Comi

  • 1Department of Neurology, Scientific Institute H San Raffaele, Via Olgettina 48, I-20132, Milan, Italy. martinelli.vittorio@hsr.it

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|January 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial.

Journal of neurology, neurosurgery, and psychiatry·2011
Same author

Voxelwise assessment of the regional distribution of damage in the brains of patients with multiple sclerosis and fatigue.

AJNR. American journal of neuroradiology·2011
Same author

Thalamic damage predicts the evolution of primary-progressive multiple sclerosis at 5 years.

AJNR. American journal of neuroradiology·2011
Same author

Cortical lesions in children with multiple sclerosis.

Neurology·2011
Same author

Sensorimotor functional connectivity changes in amyotrophic lateral sclerosis.

Cerebral cortex (New York, N.Y. : 1991)·2011
Same author

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.

European journal of neurology·2011
Same journal

Hypogonadotrophic hypogonadism in GBA2 associated spastic paraplegia type 46 (SPG46): a phenotypic expansion.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Vibrotactile stimulation induces changes in basal ganglia output, cervical muscle activity, and head posture in a patient with cervical dystonia.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Evaluating LLM diagnostic reasoning: a new frontier for clinical AI assessment.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Asymmetrical muscular disorder with normal creatine kinase (CK) and electromyography (EMG): the challenging diagnosis of muscular polyarteritis nodosa (MPAN), case report and literature review.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Neuropsychological assessment in adult epilepsy: rationale, test selection, and clinical integration across non-surgical care in Italian patients.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Early implementation of transradial mechanical thrombectomy in a primary stroke center: a sequential cohort propensity score-matched study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
See all related articles

Early treatment for multiple sclerosis (MS) using disease-modifying therapies like interferon-beta or glatiramer acetate can reduce relapses and delay neurological damage. Aggressive induction therapy or escalating treatment strategies are recommended for optimal patient outcomes.

Area of Science:

  • Neurology
  • Immunology
  • Pharmacology

Background:

  • Multiple Sclerosis (MS) management increasingly favors early therapeutic intervention.
  • Disease-modifying therapies (DMTs) like interferon-beta and glatiramer acetate are established strategies.
  • The "treat-early approach" aims to mitigate inflammatory processes and prevent irreversible neurological damage.

Purpose of the Study:

  • To review current therapeutic strategies for multiple sclerosis.
  • To discuss the benefits of early intervention and induction therapy.
  • To highlight the challenges in personalized MS treatment selection.

Main Methods:

  • Review of consensus guidelines and therapeutic approaches in Europe and America.
  • Analysis of early decision-making and "treat-early" strategies.

Related Experiment Videos

  • Evaluation of "induction therapy" versus "escalating strategies" for MS management.

    • Main Results:

    • Early treatment with interferon-beta or glatiramer acetate is widely supported.
    • Induction therapy shows potential for significant short- and long-lasting benefits, especially in high-risk patients.
    • Escalating therapy is indicated for suboptimally controlled disease, with options including mitoxantrone and cyclophosphamide.

    Conclusions:

    • Personalized therapeutic strategies are crucial for optimizing MS treatment outcomes.
    • Identifying the most effective drug or combination therapy for individual patients remains a key challenge.
    • Prompt initiation of combination therapy is advised for patients with inadequate response to monotherapy to prevent irreversible disability.